We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$49.9B
AUM Growth
+$3.67B
Cap. Flow
+$2.03B
Cap. Flow %
4.06%
Top 10 Hldgs %
18.48%
Holding
3,585
New
248
Increased
1,827
Reduced
1,181
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 9.37%
2 Financials 8.94%
3 Healthcare 8.86%
4 Industrials 6.89%
5 Communication Services 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GG
3351
CALL
DELISTED
Goldcorp Inc
GG
$6K ﹤0.01%
+64,700
New +$850K
MDLZ icon
3352
CALL
Mondelez International
MDLZ
$79.9B
$5K ﹤0.01%
17,000
-27,000
-61% -$1.15M
WLL
3353
CALL
DELISTED
Whiting Petroleum Corporation
WLL
$5K ﹤0.01%
386
+57
+17% +$83.8K
BAC icon
3354
CALL
Bank of America
BAC
$442B
$4K ﹤0.01%
18,700
-5,600
-23% -$136K
CVS icon
3355
CALL
CVS Health
CVS
$122B
$4K ﹤0.01%
18,500
+800
+5% +$63.3K
MRO
3356
CALL
DELISTED
Marathon Oil Corporation
MRO
$4K ﹤0.01%
+14,400
New +$171K
GCVRZ
3357
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$4K ﹤0.01%
10,993
HWC icon
3358
CALL
Hancock Whitney
HWC
$6.24B
$3K ﹤0.01%
13,100
-1,500
-10% -$68.7K
OVV icon
3359
CALL
Ovintiv
OVV
$16.4B
$3K ﹤0.01%
+5,040
New +$246K
TECK icon
3360
CALL
Teck Resources
TECK
$32.6B
$3K ﹤0.01%
+34,100
New +$742K
VEEV icon
3361
CALL
Veeva Systems
VEEV
$37.4B
$3K ﹤0.01%
12,900
+1,100
+9% +$66.7K
VNQ icon
3362
CALL
Vanguard Real Estate ETF
VNQ
$39B
$3K ﹤0.01%
23,100
WFC icon
3363
CALL
Wells Fargo
WFC
$264B
$3K ﹤0.01%
10,700
-1,700
-14% -$90.4K
AMD icon
3364
CALL
Advanced Micro Devices
AMD
$789B
$2K ﹤0.01%
+11,000
New +$144K
AZN icon
3365
CALL
AstraZeneca
AZN
$250B
$2K ﹤0.01%
9,200
CMCSA icon
3366
CALL
Comcast
CMCSA
$90B
$2K ﹤0.01%
+11,100
New +$437K
LUMN icon
3367
CALL
Lumen
LUMN
$6.44B
$2K ﹤0.01%
39,100
-15,800
-29% -$333K
AMLP icon
3368
CALL
Alerian MLP ETF
AMLP
$12.8B
$1K ﹤0.01%
2,180
FCX icon
3369
CALL
Freeport-McMoran
FCX
$97.5B
$1K ﹤0.01%
+17,700
New +$249K
NYT icon
3370
CALL
New York Times
NYT
$10.2B
$1K ﹤0.01%
+12,700
New +$236K
SLV icon
3371
CALL
iShares Silver Trust
SLV
$30.7B
$1K ﹤0.01%
+26,200
New +$418K
WBA
3372
CALL
DELISTED
Walgreens Boots Alliance
WBA
$1K ﹤0.01%
15,900
-18,700
-54% -$1.5M
SIOX
3373
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
1,750
CYHHZ
3374
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
36,797
+372
+1% +$5
ETP
3375
CALL
DELISTED
Energy Transfer Partners, L.P.
ETP
$1K ﹤0.01%
16,000

Similar funds

Raymond James & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Raymond James & Associates held 3,585 positions worth $49.9B, up 7.9% from $46.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.03B of net new capital in Q3 2017, opening 248 new positions and adding to 1,827 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 9.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was McDonald's, an estimated $61.8M trimmed.

  • Raymond James & Associates's largest Q3 2017 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2017, an estimated $261M increase.
  • Raymond James & Associates's biggest Q3 2017 reduction was McDonald's, cutting an estimated $61.8M.
  • Raymond James & Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $69.8M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $49.9B portfolio in Q3 2017.
  • Raymond James & Associates opened 248 new positions and closed 188 in Q3 2017.
  • Raymond James & Associates's portfolio value rose 7.9% quarter-over-quarter to $49.9B.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.